BioNTech’s mRNA Pioneers Name New Firm Arife, or ‘the Wise One’
25 Articles
25 Articles
Uğur Şahin and Özlem Türeci, the founders of BioNTech, the company known worldwide for its Covid-19 vaccine, are establishing a new biotechnology company. The new company, which will operate in Mainz, Germany, will be named "Arife".
From their first company Biontech Uğur Şahin and Özlem Türeci have withdrawn, they remain true to the location Mainz. Investors could look at this critically – but the city can cheer.
Kreiszeitung
Uğur Şahin and Özlem Türeci are founded again in Mainz. An old companion is already at the top. Personnel and mRNA rights are still under negotiation.
In Mainz it was feared that the successful research couple would leave the city. Now, however, the news came that the two founded their new company in Mainz.
The farewell of Biontech takes shape. Ugur Sahin and Özlem Türeci set up a new company. With the company they want to develop a new generation of medicines.
Uğur Şahin and Özlem Türeci set up a new company for mRNA therapies with Arife. Find out what is behind the restart and what role Biontech plays.
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
